Baird Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $137M | Sell |
1,064,683
-98,410
| -8% | -$11.5M | 0.19% | 84 |
|
|
2026
Q1 | $140M | Sell |
1,163,093
-132,928
| -10% | -$15.3M | 0.22% | 79 |
|
|
2025
Q4 | $136M | Buy |
1,296,021
+29,226
| +2% | +$2.74M | 0.21% | 76 |
|
|
2025
Q3 | $106M | Buy |
1,266,795
+19,629
| +2% | +$1.62M | 0.17% | 93 |
|
|
2025
Q2 | $98.7M | Sell |
1,247,166
-191,756
| -13% | -$15.2M | 0.17% | 100 |
|
|
2025
Q1 | $129M | Sell |
1,438,922
-499,779
| -26% | -$46.7M | 0.25% | 76 |
|
|
2024
Q4 | $193M | Sell |
1,938,701
-165,748
| -8% | -$17.1M | 0.37% | 58 |
|
|
2024
Q3 | $239M | Buy |
2,104,449
+2,883
| +0.1% | +$343K | 0.46% | 43 |
|
|
2024
Q2 | $260M | Sell |
2,101,566
-32,012
| -2% | -$4.12M | 0.54% | 38 |
|
|
2024
Q1 | $282M | Sell |
2,133,578
-49,373
| -2% | -$6.09M | 0.59% | 36 |
|
|
2023
Q4 | $238M | Sell |
2,182,951
-199,862
| -8% | -$20.7M | 0.54% | 38 |
|
|
2023
Q3 | $245M | Sell |
2,382,813
-24,602
| -1% | -$2.65M | 0.67% | 29 |
|
|
2023
Q2 | $278M | Sell |
2,407,415
-46,100
| -2% | -$5.23M | 0.73% | 24 |
|
|
2023
Q1 | $261M | Sell |
2,453,515
-23,286
| -0.9% | -$2.51M | 0.64% | 30 |
|
|
2022
Q4 | $275M | Sell |
2,476,801
-569,981
| -19% | -$58.3M | 0.72% | 28 |
|
|
2022
Q3 | $262M | Sell |
3,046,782
-102,251
| -3% | -$9.13M | 0.77% | 25 |
|
|
2022
Q2 | $287M | Buy |
3,149,033
+148,257
| +5% | +$13.1M | 0.8% | 22 |
|
|
2022
Q1 | $246M | Buy |
3,000,776
+71,349
| +2% | +$5.63M | 0.61% | 30 |
|
|
2021
Q4 | $225M | Sell |
2,929,427
-115,286
| -4% | -$9.18M | 0.52% | 37 |
|
|
2021
Q3 | $229M | Buy |
3,044,713
+138,508
| +5% | +$10.5M | 0.58% | 34 |
|
|
2021
Q2 | $226M | Buy |
2,906,205
+160,297
| +6% | +$11.9M | 0.59% | 31 |
|
|
2021
Q1 | $202M | Buy |
2,745,908
+307,908
| +13% | +$22.7M | 0.57% | 35 |
|
|
2020
Q4 | $190M | Sell |
2,438,000
-17,405
| -0.7% | -$1.33M | 0.57% | 33 |
|
|
2020
Q3 | $194M | Buy |
2,455,405
+298,433
| +14% | +$23.4M | 0.67% | 26 |
|
|
2020
Q2 | $159M | Buy |
2,156,972
+121,264
| +6% | +$9.13M | 0.6% | 30 |
|
|
2020
Q1 | $149M | Sell |
2,035,708
-52,536
| -3% | -$4.13M | 0.68% | 27 |
|
|
2019
Q4 | $181M | Buy |
2,088,244
+36,492
| +2% | +$3M | 0.65% | 28 |
|
|
2019
Q3 | $165M | Buy |
2,051,752
+19,093
| +0.9% | +$1.53M | 0.65% | 27 |
|
|
2019
Q2 | $163M | Buy |
2,032,659
+343,184
| +20% | +$26.3M | 0.63% | 29 |
|
|
2019
Q1 | $134M | Sell |
1,689,475
-72,074
| -4% | -$5.39M | 0.78% | 18 |
|
|
2018
Q4 | $128M | Buy |
1,761,549
+149,266
| +9% | +$10.5M | 0.87% | 17 |
|
|
2018
Q3 | $110M | Sell |
1,612,283
-2,641
| -0.2% | -$168K | 0.69% | 19 |
|
|
2018
Q2 | $93.5M | Buy |
1,614,924
+84,685
| +6% | +$4.78M | 0.63% | 20 |
|
|
2018
Q1 | $79.5M | Buy |
1,530,239
+62,598
| +4% | +$3.38M | 0.56% | 28 |
|
|
2017
Q4 | $78.8M | Buy |
1,467,641
+258,235
| +21% | +$14.3M | 0.56% | 29 |
|
|
2017
Q3 | $73.9M | Sell |
1,209,406
-17,196
| -1% | -$1.04M | 0.56% | 29 |
|
|
2017
Q2 | $75M | Buy |
1,226,602
+29,778
| +2% | +$1.81M | 0.59% | 27 |
|
|
2017
Q1 | $72.6M | Sell |
1,196,824
-294
| -0% | -$17.8K | 0.59% | 26 |
|
|
2016
Q4 | $67.2M | Buy |
1,197,118
+52,306
| +5% | +$3.06M | 0.58% | 28 |
|
|
2016
Q3 | $68.2M | Buy |
1,144,812
+1,603
| +0.1% | +$93.7K | 0.61% | 25 |
|
|
2016
Q2 | $63.2M | Buy |
1,143,209
+1,901
| +0.2% | +$101K | 0.58% | 27 |
|
|
2016
Q1 | $57.6M | Buy |
1,141,308
+605,676
| +113% | +$29.7M | 0.55% | 29 |
|
|
2015
Q4 | $27M | Buy |
535,632
+26,938
| +5% | +$1.36M | 0.27% | 105 |
|
|
2015
Q3 | $24M | Sell |
508,694
-4,727
| -0.9% | -$251K | 0.25% | 114 |
|
|
2015
Q2 | $27.9M | Buy |
+513,421
| New | +$28.8M | 0.27% | 113 |
|
Other funds holding MRK
Baird Financial Group's MRK Position: Q2 2026 in Review
Baird Financial Group reduced its Merck (MRK) stake by 8.5% in Q2 2026, selling an estimated $11.5M and leaving 1,064,683 shares worth $137M. The position accounts for 0.19% of the portfolio, ranked #84.
Baird Financial Group first reported a position in MRK in Q2 2015 and has held it in 45 quarters since. The position peaked at $287M in Q2 2022. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Baird Financial Group held 1,064,683 shares of Merck worth $137M as of Q2 2026.
- Baird Financial Group sold 98,410 Merck shares in Q2 2026, an estimated $11.5M.
- Merck made up 0.19% of Baird Financial Group's portfolio in Q2 2026, its #84 holding.
- Baird Financial Group first reported a position in Merck in Q2 2015 and has held it in 45 quarters since.
- Baird Financial Group's Merck position peaked at $287M in Q2 2022.
- 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.